[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Redeye_ Redeye Redeye posts on X about $ver, $geno, $vit, $acti the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::153838561/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX -XXXX% - X Year XXXXXXXXX -XXXX% ### Mentions: XX [#](/creator/twitter::153838561/posts_active)  - X Week XX -XX% - X Month XX -XX% - X Months XXX +24% - X Year XXXXX +40% ### Followers: XXXXXX [#](/creator/twitter::153838561/followers)  - X Week XXXXXX +0.10% - X Month XXXXXX +0.13% - X Months XXXXXX -XXXX% - X Year XXXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::153838561/influencer_rank)  ### Social Influence [#](/creator/twitter::153838561/influence) --- **Social category influence** [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% [exchanges](/list/exchanges) XXXX% [stocks](/list/stocks) XXXX% **Social topic influence** [$ver](/topic/$ver) #4, [$geno](/topic/$geno) #1, [$vit](/topic/$vit) #2, [$acti](/topic/$acti) 0.27%, [$avt](/topic/$avt) 0.27%, [currency](/topic/currency) 0.27%, [$chef](/topic/$chef) 0.27%, [longterm](/topic/longterm) 0.27%, [$dvysr](/topic/$dvysr) 0.27%, [acquisition](/topic/acquisition) XXXX% **Top accounts mentioned or mentioned by** [@smarteyeab](/creator/undefined) [@longriver_hk](/creator/undefined) [@safelloab](/creator/undefined) [@taocat_agent](/creator/undefined) [@10_ch_10](/creator/undefined) [@tomasotterbeck](/creator/undefined) [@thome_fole](/creator/undefined) [@fredrikkjell](/creator/undefined) [@michaelgielkens](/creator/undefined) [@simplerinvestor](/creator/undefined) [@chad_pumpiano](/creator/undefined) [@saeschinv](/creator/undefined) **Top assets mentioned** [GenomeFi (GENO)](/topic/$geno) [Team Vitality Fan Token (VIT)](/topic/$vit) [Aventus (AVT)](/topic/$avt) [Biconomy (BICO)](/topic/$bico) [Deere & Company (DE)](/topic/$de) ### Top Social Posts [#](/creator/twitter::153838561/posts) --- Top posts by engagements in the last XX hours "Redeye comments on Verve Groups Q2 2025 results and the lowered full-year guidance. $VER" [X Link](https://x.com/Redeye_/status/1956252758702432763) [@Redeye_](/creator/x/Redeye_) 2025-08-15T07:12Z 14.5K followers, 1793 engagements "Redeye comments on Active Biotech's second quarter report. $ACTI" [X Link](https://x.com/Redeye_/status/1959952051355386034) [@Redeye_](/creator/x/Redeye_) 2025-08-25T12:12Z 14.5K followers, XXX engagements "Redeye comments on a preliminary release ahead of its full report on XX October 2025 where AVTECH announced Q3 2025 net sales of SEK12.3 million representing XX% year-over-year growth despite adverse currency movements. $AVT" [X Link](https://x.com/Redeye_/status/1975082794624991490) [@Redeye_](/creator/x/Redeye_) 2025-10-06T06:16Z 14.5K followers, XXX engagements "Redeye provides a comment on the Q3 trading update from Cheffelo released this morning. $CHEF" [X Link](https://x.com/Redeye_/status/1976552806464049309) [@Redeye_](/creator/x/Redeye_) 2025-10-10T07:38Z 14.5K followers, 1234 engagements "Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO" [X Link](https://x.com/Redeye_/status/1940346251234640071) [@Redeye_](/creator/x/Redeye_) 2025-07-02T09:46Z 14.5K followers, 1449 engagements "Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO" [X Link](https://x.com/Redeye_/status/1955189857602469971) [@Redeye_](/creator/x/Redeye_) 2025-08-12T08:49Z 14.5K followers, 1009 engagements "Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO" [X Link](https://x.com/Redeye_/status/1955529686043501021) [@Redeye_](/creator/x/Redeye_) 2025-08-13T07:19Z 14.5K followers, 1139 engagements "Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR" [X Link](https://x.com/Redeye_/status/1961072328944636250) [@Redeye_](/creator/x/Redeye_) 2025-08-28T14:24Z 14.5K followers, 1216 engagements "Redeye comments on Verve's announced acquisition. $VER" [X Link](https://x.com/Redeye_/status/1968331752470097950) [@Redeye_](/creator/x/Redeye_) 2025-09-17T15:10Z 14.5K followers, 1335 engagements "Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER" [X Link](https://x.com/Redeye_/status/1970009407556649224) [@Redeye_](/creator/x/Redeye_) 2025-09-22T06:16Z 14.5K followers, 1416 engagements "BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO" [X Link](https://x.com/Redeye_/status/1975477431659340000) [@Redeye_](/creator/x/Redeye_) 2025-10-07T08:24Z 14.5K followers, 1156 engagements "Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE" [X Link](https://x.com/Redeye_/status/1978381140831457496) [@Redeye_](/creator/x/Redeye_) 2025-10-15T08:43Z 14.5K followers, XXX engagements "Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT" [X Link](https://x.com/Redeye_/status/1978738525576024436) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:23Z 14.5K followers, XXX engagements "Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX" [X Link](https://x.com/Redeye_/status/1978738980804825380) [@Redeye_](/creator/x/Redeye_) 2025-10-16T08:25Z 14.5K followers, 1036 engagements "Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT" [X Link](https://x.com/Redeye_/status/1979058100423291260) [@Redeye_](/creator/x/Redeye_) 2025-10-17T05:33Z 14.5K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Redeye posts on X about $ver, $geno, $vit, $acti the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence cryptocurrencies XXXX% finance XXXX% exchanges XXXX% stocks XXXX%
Social topic influence $ver #4, $geno #1, $vit #2, $acti 0.27%, $avt 0.27%, currency 0.27%, $chef 0.27%, longterm 0.27%, $dvysr 0.27%, acquisition XXXX%
Top accounts mentioned or mentioned by @smarteyeab @longriver_hk @safelloab @taocat_agent @10_ch_10 @tomasotterbeck @thome_fole @fredrikkjell @michaelgielkens @simplerinvestor @chad_pumpiano @saeschinv
Top assets mentioned GenomeFi (GENO) Team Vitality Fan Token (VIT) Aventus (AVT) Biconomy (BICO) Deere & Company (DE)
Top posts by engagements in the last XX hours
"Redeye comments on Verve Groups Q2 2025 results and the lowered full-year guidance. $VER"
X Link @Redeye_ 2025-08-15T07:12Z 14.5K followers, 1793 engagements
"Redeye comments on Active Biotech's second quarter report. $ACTI"
X Link @Redeye_ 2025-08-25T12:12Z 14.5K followers, XXX engagements
"Redeye comments on a preliminary release ahead of its full report on XX October 2025 where AVTECH announced Q3 2025 net sales of SEK12.3 million representing XX% year-over-year growth despite adverse currency movements. $AVT"
X Link @Redeye_ 2025-10-06T06:16Z 14.5K followers, XXX engagements
"Redeye provides a comment on the Q3 trading update from Cheffelo released this morning. $CHEF"
X Link @Redeye_ 2025-10-10T07:38Z 14.5K followers, 1234 engagements
"Redeye comments on Genovis decision to acquire the remaining XX% of SEQURNA viewing it as a logical synergistic move that leverages its growing net cash and adds exposure to the sizable and growing genomics market. $GENO"
X Link @Redeye_ 2025-07-02T09:46Z 14.5K followers, 1449 engagements
"Redeye's view of Genovis Q2 report is balanced sales were largely in line but profitability was softer than we had estimated. $GENO"
X Link @Redeye_ 2025-08-12T08:49Z 14.5K followers, 1009 engagements
"Redeye updates its view on Genovis' following a Q2 2025 report falling slightly short of our estimates and the recently expanded licese agreement with Thermo Fischer which we find supportive to the long-term case. $GENO"
X Link @Redeye_ 2025-08-13T07:19Z 14.5K followers, 1139 engagements
"Redeye comments on the now confirmed partnering with industry giant Quest Diagnostics for channel coverage of Devysers RHD test kit. $DVYSR"
X Link @Redeye_ 2025-08-28T14:24Z 14.5K followers, 1216 engagements
"Redeye comments on Verve's announced acquisition. $VER"
X Link @Redeye_ 2025-09-17T15:10Z 14.5K followers, 1335 engagements
"Redeye updates its valuation of Verve which within two days announced two acquisitions that complement each other well. $VER"
X Link @Redeye_ 2025-09-22T06:16Z 14.5K followers, 1416 engagements
"BICO Group is trading below Redeye's Base Case. We spoke with our analyst regarding BICO's business model key challenges and other key topics. This is a premium article included in our paid plans from SEK 99/month. $BICO"
X Link @Redeye_ 2025-10-07T08:24Z 14.5K followers, 1156 engagements
"Top Picks provides an update following a change in the Alternative Picks list taking profit on a position that has played out as expected. Top Picks is included in our premium memberships from SEK 349/month. $DE"
X Link @Redeye_ 2025-10-15T08:43Z 14.5K followers, XXX engagements
"Redeye provides its initial take on Vitecs Q3 2025 report which came in broadly below our estimates. $VIT"
X Link @Redeye_ 2025-10-16T08:23Z 14.5K followers, XXX engagements
"Redeye shares its preview of BONESUPPORTs Q3 2025 results due October XX. $BONEX"
X Link @Redeye_ 2025-10-16T08:25Z 14.5K followers, 1036 engagements
"Redeye updates its estimates and valuation after Vitecs Q3 2025 report. $VIT"
X Link @Redeye_ 2025-10-17T05:33Z 14.5K followers, XXX engagements
/creator/twitter::Redeye_